New Innovate UK Funding Scheme: Biomedical Catalyst 2022 Round One

Friday 01 April 2022

Innovate UK, part of UK Research and Innovation will invest up to £15 million in projects to support UK registered businesses to develop innovative health or healthcare-focussed products, technologies and processes.

Projects may include (but are not limited to):

  • Disease prevention and proactive management of health and chronic conditions
  • Earlier and better detection and diagnosis of disease, leading to better patient outcomes
  • Tailored treatments that either change the underlying disease or offer potential cures
  • The development of digital health technologies

The Industry-led research and development (R&D) stream of the Biomedical Catalyst programme supports pre-market R&D projects. Applicants must be able to demonstrate existing evidence of commercial and technical feasibility.

The scheme is designed for projects with total costs between £150,000 and £4 million, and projects must last between 6 to 36 months with an end date of 30 November at the latest.

Applications opened on 28 March and applications are accepted until 25 May 11:00am.